Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Fecal Metabolic Profiling of Breast Cancer Patients during Neoadjuvant Chemotherapy Reveals Potential Biomarkers
O. Zidi, Nessrine Souai, Henda Raies, et al.
Molecules (2021) Vol. 26, Iss. 8, pp. 2266-2266
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Liquid Biopsy as a Tool for the Diagnosis, Treatment, and Monitoring of Breast Cancer
Ana Julia Aguiar de Freitas, Rhafaela Lima Causin, Muriele Bertagna Varuzza, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 9952-9952
Open Access | Times Cited: 72
Review-Enzymatic and Non-Enzymatic Electrochemical Sensor for Lactate Detection in Human Biofluids
Muhammad Faiz Md Shakhih, Anis Suzziani Rosslan, Anas Mohd Noor, et al.
Journal of The Electrochemical Society (2021) Vol. 168, Iss. 6, pp. 067502-067502
Closed Access | Times Cited: 46
The role of gut microbiota and metabolites in cancer chemotherapy
Shiyu Li, Shuangli Zhu, Jun Yu
Journal of Advanced Research (2023) Vol. 64, pp. 223-235
Open Access | Times Cited: 19
Chemotherapy-induced gut microbiome disruption, inflammation, and cognitive decline in female patients with breast cancer
Lauren Otto, Corena V. Grant, Ashley A. Lahoud, et al.
Brain Behavior and Immunity (2024) Vol. 120, pp. 208-220
Closed Access | Times Cited: 6
The conundrum of breast cancer and microbiome - A comprehensive review of the current evidence
Andri Papakonstantinou, Paolo Nucíforo, María Borrell, et al.
Cancer Treatment Reviews (2022) Vol. 111, pp. 102470-102470
Closed Access | Times Cited: 26
The Interplay between Microbiota and Chemotherapy-Derived Metabolites in Breast Cancer
Julio Plaza‐Díaz, Ana I. Álvarez‐Mercado
Metabolites (2023) Vol. 13, Iss. 6, pp. 703-703
Open Access | Times Cited: 11
Obesity, dysbiosis and inflammation: interactions that modulate the efficacy of immunotherapy
Ashutosh S. Yende, Dipali Sharma
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
A deep learning approach for early prediction of breast cancer neoadjuvant chemotherapy response on multistage bimodal ultrasound images
Jiang Xie, Jinzhu Wei, Huachan Shi, et al.
BMC Medical Imaging (2025) Vol. 25, Iss. 1
Open Access
Pharmacometabolomics: An emerging platform for understanding the pathophysiological processes and therapeutic interventions
Chandra Prakash, Patrick Moran, Rohit Mahar
International Journal of Pharmaceutics (2025), pp. 125554-125554
Closed Access
Liquid-based biomarkers in breast cancer: looking beyond the blood
You Shuai, Zhonghua Ma, Jie Ju, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 9
Metabolic Profiling of Bladder Cancer Patients’ Serum Reveals Their Sensitivity to Neoadjuvant Chemotherapy
Juntao Zhuang, Xiao Yang, Qi Zheng, et al.
Metabolites (2022) Vol. 12, Iss. 6, pp. 558-558
Open Access | Times Cited: 14
Targeting the gut microbiota to alleviate chemotherapy-induced toxicity in cancer
Yaning Xu, Haiyan Du, Yu‐Chun Chen, et al.
Critical Reviews in Microbiology (2023) Vol. 50, Iss. 5, pp. 564-580
Closed Access | Times Cited: 8
A Clinical Trial of the Effects of a Dietary Pattern on Health Metrics and Fecal Metabolites in Volunteers With Risk of Cardiovascular Disease
Kunchen HAN, Jinke Ma, Junxia Dou, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 13
Gastrointestinal Microbiota and Breast Cancer Chemotherapy Interactions: A Systematic Review
Denise Csendes, Sai Dheeraj Gutlapalli, Keerthana Prakash, et al.
Cureus (2022)
Open Access | Times Cited: 11
Metabolomic Profiling of Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy for Predicting Disease-Free and Overall Survival
Maria Cecília Ramiro Talarico, Sophie Derchain, Lucas Ferreira da Silva, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 8639-8639
Open Access | Times Cited: 2
Gut microbiota-drug interactions in cancer pharmacotherapies: implications for efficacy and adverse effects
Sarah‐Jane Leigh, Caoimhe M.K. Lynch, Brian Bird, et al.
Expert Opinion on Drug Metabolism & Toxicology (2022) Vol. 18, Iss. 1, pp. 5-26
Open Access | Times Cited: 8
Mechanism of inflammasomes in cancer and targeted therapies
Qingdan Gu, Jiazhen Zou, Ying Zhou, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 4
Metabolic Profiling of Aromatic Compounds
Alisa Pautova
Metabolites (2024) Vol. 14, Iss. 2, pp. 107-107
Open Access | Times Cited: 1
Comprehensive Metabolomic Analysis of Lung Cancer Patients Treated with Fu Zheng Fang
Yongjuan Ding, Juan Lv, Yujiao Hua
Current Pharmaceutical Analysis (2022) Vol. 18, Iss. 9, pp. 881-891
Closed Access | Times Cited: 7
Pharmacometabolomics by NMR in Oncology: A Systematic Review
Nuria Gómez-Cebrián, Pedro Vazquez‐Ferreiro, Francisco Javier Carrera Hueso, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 10, pp. 1015-1015
Open Access | Times Cited: 6
The Microbiome: A New Frontier in Overcoming Drug Resistance in Breast Cancer
Thifhelimbilu Emmanuel Luvhengo, Thabiso Victor Miya, Afra Basera, et al.
(2024), pp. 261-285
Closed Access
Liquid Biopsy and its significance on the Early Detection of Breast Cancer
Farkhonde Hasannejad, Ahmad Fazilat, Keivan Majidzadeh‐A
Deleted Journal (2024) Vol. 17, Iss. 3, pp. 55-81
Closed Access
Baseline gut microbiome alpha diversity predicts chemotherapy-induced gastrointestinal symptoms in patients with breast cancer
Lauren Otto, Lindsay Strehle, Brett R. Loman, et al.
npj Breast Cancer (2024) Vol. 10, Iss. 1
Open Access
The oral-gut microbiome axis in breast cancer: from basic research to therapeutic applications
Lan Huang, Chun Jiang, Meina Yan, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access
Biogenic Amines in Gliomas: A Comprehensive Literature Review
Ahmad Abuaisheh, Orwa Aboud
Frontiers in Bioscience-Landmark (2023) Vol. 28, Iss. 7
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top